Search results
Aug 17, 2022 · Essential thrombocythemia is a rare genetic disorder that causes high platelet levels and increases the risk of blood clots. Learn about the diagnosis, management and outlook of this condition and how it affects pregnancy.
May 17, 2023 · Learn about the median survival time, risk factors, and treatment options for essential thrombocythemia (ET), a rare blood condition that causes high platelet levels. ET does not shorten lifespan significantly, but can lead to serious complications like blood clots and transformation to leukemia.
To describe the long-term natural history of essential thrombocythemia (ET) in terms of life expectancy, risk of disease transformation into a more aggressive myeloid disorder, and prognostic factors for both survival and disease complications.
- Alexandra P. Wolanskyj, Susan M. Schwager, Rebecca F. McClure, Dirk R. Larson, Ayalew Tefferi
- 2006
Dec 28, 2020 · ET is characterized by overall favorable prognosis if compared to the other MPNs (but life-expectancy in ET is shorter than the general population) with an expected survival of 18 to 19.8 years (compared to 13.5 years in PV and 5.9 years in PMF).
- Vincenzo Accurso, Marco Santoro, Salvatrice Mancuso, Mariasanta Napolitano, Melania Carlisi, Marta M...
- 10.1177/2634853520978210
- 2020
- 2020
Learn about essential thrombocythemia, a clonal disorder that causes high platelet count and increased risk of bleeding or thrombosis. Find out the etiology, pathophysiology, symptoms, diagnosis, treatment, and prognosis of this condition.
Jan 16, 2024 · Learn about the management and outlook of essential thrombocythemia (ET), a myeloproliferative neoplasm with excessive platelet production. ET has the most favorable prognosis among the BCR::ABL1 MPNs, but may cause thrombosis, bleeding, or progression.
People with essential thrombocytosis usually have a normal life span, but some develop polycythemia vera (usually females) or myelofibrosis (usually males).
